Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Sangamo Therapeutics Q1 GAAP EPS $(0.14) Misses $(0.13) Estimate, Sales $6.44M Miss $7.42M Estimate

Author: Benzinga Newsdesk | May 12, 2025 03:37pm
Sangamo Therapeutics (NASDAQ:SGMO) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 7.69 percent. This is a 48.15 percent increase over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $6.44 million which missed the analyst consensus estimate of $7.42 million by 13.21 percent. This is a 1.24K percent increase over sales of $481.00 thousand the same period last year.

Posted In: SGMO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist